News

Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks

No Picture
News

Quantori and Expert Systems Partner to Accelerate Drug Discovery with Foundational Predictive AI Models

December 18, 2025 SDBN Comments Off on Quantori and Expert Systems Partner to Accelerate Drug Discovery with Foundational Predictive AI Models

CAMBRIDGE, Mass. & SAN DIEGO–(BUSINESS WIRE)–Quantori and Expert Systems partner to integrate foundational predictive AI models into Q-Scientist, accelerating smarter, faster drug discovery. Click here to view original post Click Here to Publish/Feature Your Company […]

News

Innovating Diagnostics and What’s Next

December 18, 2025 SDBN Comments Off on Innovating Diagnostics and What’s Next

SAN DIEGO, Dec. 18, 2025 /PRNewswire/ — QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes podcast, featuring Jonathan Siegrist, PhD, Executive Vice President of […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

December 18, 2025 SDBN Comments Off on MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

LA JOLLA, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced […]

News

U.S. FDA Approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Co-Formulated with ENHANZE® for the Treatment of Advanced EGFR-mutated Non-Small Cell Lung Cancer

December 18, 2025 SDBN Comments Off on U.S. FDA Approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Co-Formulated with ENHANZE® for the Treatment of Advanced EGFR-mutated Non-Small Cell Lung Cancer

RYBREVANT FASPRO™ is approved across all indications of RYBREVANT® (amivantamab-vmjw) SAN DIEGO, Dec. 18, 2025 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Johnson & Johnson has received approval from the U.S. […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection

December 17, 2025 SDBN Comments Off on Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection

LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough Genomics, a leader in the clinical […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program

December 16, 2025 SDBN Comments Off on Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program

SAN DIEGO, Dec. 16, 2025 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology today announced an update on the INBRX-106 Phase 2/3 […]

News

Blue Shield of California Promise Health Plan Sponsors $80,000 in Medical Assistant Training Scholarships in San Diego County

December 16, 2025 SDBN Comments Off on Blue Shield of California Promise Health Plan Sponsors $80,000 in Medical Assistant Training Scholarships in San Diego County

SAN DIEGO, Dec. 16, 2025 /PRNewswire/ — Blue Shield of California Promise Health Plan announced today the sponsorship of scholarships to support students taking part in the Laura Rodriguez Medical Assistant Institute (LRMAI), an education […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

A Study Published in European Urology Oncology Demonstrated Bladder EpiCheck® Can Detect High-Grade Bladder Cancer Recurrences Missed by White Light Cystoscopy

December 16, 2025 SDBN Comments Off on A Study Published in European Urology Oncology Demonstrated Bladder EpiCheck® Can Detect High-Grade Bladder Cancer Recurrences Missed by White Light Cystoscopy

SAN DIEGO & REHOVOT, Israel–(BUSINESS WIRE)–Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that European Urology Oncology published results of a clinical study demonstrating the implications of implementing […]

No Picture
News

Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

December 15, 2025 SDBN Comments Off on Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

EMERYVILLE, Calif.–(BUSINESS WIRE)—- $OABI #OABI–OmniAb, Inc. (NASDAQ: OABI) announces the launch of its new OmniUltra™ platform, the industry’s first and only transgenic chicken engineered to express ultralong CDRH3 domains on a human antibody framework, at […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

SOLVD Health Publishes Peer-Reviewed Framework to Advance Clinical Use of Genomic Data

December 15, 2025 SDBN Comments Off on SOLVD Health Publishes Peer-Reviewed Framework to Advance Clinical Use of Genomic Data

SAN DIEGO–(BUSINESS WIRE)–SOLVD Health, a patient intelligence company developing cutting-edge precision solutions to deliver better health outcomes, has published a peer-reviewed article in the International Journal of Molecular Sciences on best practices for the clinical […]

No Picture
News

ALZpath and Siemens Healthineers Sign Licensing Agreement to Advance Global Access to Blood-Based Alzheimer’s Disease Diagnostic Testing

December 15, 2025 SDBN Comments Off on ALZpath and Siemens Healthineers Sign Licensing Agreement to Advance Global Access to Blood-Based Alzheimer’s Disease Diagnostic Testing

Siemens Healthineers will utilize ALZpath’s high-performing, proprietary pTau217 antibody in its growing test menu for its Atellica analyzers to enable IVD testing for Alzheimer’s disease CARLSBAD, Calif., Dec. 15, 2025 /PRNewswire/ — ALZpath, Inc., a […]

News

ARDT INVESTIGATION ALERT: Investigation Launched into Ardent Health, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – ARDT

December 12, 2025 SDBN Comments Off on ARDT INVESTIGATION ALERT: Investigation Launched into Ardent Health, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – ARDT

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT) focused on whether Ardent Health and certain […]


ADVERTISEMENT — Advertise With Biotech Networks
News

KVP International Acquires SafePath Laboratories and IVD Research, Expanding Its Capabilities in Diagnostics

December 12, 2025 SDBN Comments Off on KVP International Acquires SafePath Laboratories and IVD Research, Expanding Its Capabilities in Diagnostics

Carlsbad, California–based diagnostics manufacturer, SafePath-IVD, to serve as KVP’s research, development and manufacturing partner while continuing to grow its CDMO diagnostics business. MCKINNEY, Texas, Dec. 12, 2025 /PRNewswire/ — KVP International, the Better Pet Care […]

No Picture
News

Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome

December 12, 2025 SDBN Comments Off on Acadia Pharmaceuticals Announces FDA Approval of DAYBUE® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Food and Drug Administration (FDA) has approved DAYBUE® STIX (trofinetide) for oral solution, a dye- and preservative-free powder formulation of trofinetide for the […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2025 San Antonio Breast Cancer Symposium

December 11, 2025 SDBN Comments Off on Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2025 San Antonio Breast Cancer Symposium

SAN DIEGO, Calif.–(BUSINESS WIRE)–Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2025 SABCS Click here to view original post Click Here to Publish/Feature Your […]

News

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

December 11, 2025 SDBN Comments Off on Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Partnership unites Illumina’s leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO and MENLO PARK, Calif., Dec. 11, 2025 /PRNewswire/ — Illumina, Inc. […]